itraconazole and Parkinson Disease

itraconazole has been researched along with Parkinson Disease in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Bani, M; Basile, P; Biere, AL; Carson, S; Detalle, L; Domange, C; Genius, J; Germani, M; Lalla, M; Mathy, FX; Prato, MK; Schmidt, A; Smit, JW	1
Christensen, J; Dupont, E; ØStergaard, K	1
Alvareda, D; Silva, V; Zepeda, G	1

Trials

1 trial(s) available for itraconazole and Parkinson Disease

Article	Year
Phase 1/1b Studies of UCB0599, an Oral Inhibitor of α-Synuclein Misfolding, Including a Randomized Study in Parkinson's Disease. Movement disorders : official journal of the Movement Disorder Society, 2022, Volume: 37, Issue:10 Topics: alpha-Synuclein; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Itraconazole; Parkinson Disease	2022

Other Studies

2 other study(ies) available for itraconazole and Parkinson Disease

Article	Year
Cabergoline plasma concentration is increased during concomitant treatment with itraconazole. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6 Topics: Adult; Aged; Antifungal Agents; Antiparkinson Agents; Cabergoline; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ergolines; Female; Humans; Itraconazole; Male; Neurologic Examination; Onychomycosis; Parkinson Disease; Treatment Outcome	2002
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile]. Revista iberoamericana de micologia, 2003, Volume: 20, Issue:1 Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt	2003

Article

Year

Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.

Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:6

Topics: Adult; Aged; Antifungal Agents; Antiparkinson Agents; Cabergoline; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Ergolines; Female; Humans; Itraconazole; Male; Neurologic Examination; Onychomycosis; Parkinson Disease; Treatment Outcome

2002

[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].

Revista iberoamericana de micologia, 2003, Volume: 20, Issue:1

Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt

2003